{"title": "PDF", "author": "PDF", "url": "https://www.broadinstitute.org/files/patents/WO2018049025.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "[00114] fromagroup comprising; mutated proteins, genetically engineered proteins, peptides, synthetic peptides, recombinant proteins, chimeric proteins, antibodies, midibodies, minibodies, fromagroupcomprising mutated proteins, genetically engineered proteins, peptides, synthetic peptides, recombinant proteins, chimeric proteins, antibodies, midibodies, minibodies, delivery vehicles, vectors, ANDCOMPOSITIONS FOR TARGETING DISORDERS ANDDISEASES USING PARTICLE DELIVERY autoimmune significant declineinameasurable practitioner (e.g.,physician, veterinarian), particles comprising polymer conjugated toasurfactant, hydrophilic orlipid.USPatentNo.6,007,845, complex ofa positively opposite iscarriedoutbyidentifying asubject,e.g.,ahumanpatientsuffering from (oratriskofdeveloping) animmune-related disorder therapy. Standards ofCareforcancergenerally includesurgery, lymphnoderemoval, whiletheTcelldysfunction "}